pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 12·1 min read
save

Veteran researcher warns new OMB grant rule could politicize U.S. science

Jun 12, 2026·read at STAT ↗RegulatoryNegative

David J. Skorton, president of the Association of American Medical Colleges, writes that after four decades in research he has never seen a threat to science like the new grantmaking rule being considered by the Office of Management and Budget. He argues the proposal would subject federal research funding to heightened political scrutiny.

The OMB draft would change how grants are evaluated, effectively allowing political considerations to influence which projects receive federal support. Skorton says this would undermine the established guardrails that have kept U.S. science insulated from partisan swings.

He points to historic achievements-from turning childhood leukemia into a largely survivable disease to advances in cancer immunotherapy and the development of GPS, semiconductors, and early internet architecture-as proof of what a protected research enterprise can deliver. He warns that eroding these protections could jeopardize future breakthroughs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule”

read at STAT ↗
1,095 words · retrieved Jun 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATHThe Medicines Co
drugs
LITHIUM
topics
Oncology4Cystic Fibrosis

related stories

  • 5h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 18New hope in treating Huntington’s disease and a report card on RFK Jr.’s promisesSTAT
  • Jun 18Pfizer CFO to step down; Denali sells a regulatory fast-passBioPharma Dive
  • Jun 17Trump administration will bring special ed to HHSSTAT